E Finanger, K Vandenborne,
RS Finkel… - Journal of …, 2019 - content.iospress.com
Background: Edasalonexent is an orally administered small molecule designed to inhibit NF-
κB, which is activated from infancy in Duchenne muscular dystrophy and is central to …